DNA X, Inc.
SONM
$3.94
-$0.54-12.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -86.98% | 36.41% | -1,732.10% | 102.12% | -760.43% |
| Total Depreciation and Amortization | 57.14% | 19.45% | -24.45% | 15.43% | -0.44% |
| Total Amortization of Deferred Charges | -- | -100.00% | -- | -- | -- |
| Total Other Non-Cash Items | -170.26% | -61.70% | 115.86% | -313.61% | 53.02% |
| Change in Net Operating Assets | 230.49% | -3,967.82% | 98.57% | -157.56% | 3,002.75% |
| Cash from Operations | 71.51% | -44.08% | 49.18% | -113.04% | -981.29% |
| Capital Expenditure | -- | -- | -- | -- | 94.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 94.16% |
| Total Debt Issued | -45.69% | 4,649.02% | -101.80% | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -102.60% | -10.53% | 53.10% | 1,592.34% | 1,392.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -83.67% | 50.12% | -25.16% | 697.25% | 5,614.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -736.64% | 220.18% | 96.62% | 13.16% | -588.33% |